Company / Income Tax
CUMBERLAND PHARMACEUTICALS INC Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$40.3K
FY2025
5-year range
-$79.3K / $68.8K
FY2021-FY2025
Trend
-12.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax has fluctuated over the past 10 years, ranging from -$330,924 in FY2018 to $1M in FY2016.
Based on SEC 10-K filings.
$40,256 in FY2025 with a 5-year CAGR of -6.4%.
Improved from $68,850 to $40,256 over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- +4.9%
- 5-Year CAGR
- -6.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -6.4%, indicating a declining trend.
- In FY2025, income tax decreased 12.0% year-over-year.
- Peak income tax was recorded in FY2016.
- Lowest income tax in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $40.3K | -12.0% |
| FY2024 | $45.8K | -33.5% |
| FY2023 | $68.8K | +97.3% |
| FY2022 | $34.9K | +144.0% |
| FY2021 | -$79.3K | -241.9% |
| FY2020 | $55.9K | +170.5% |
| FY2019 | -$79.3K | +76.0% |
| FY2018 | -$330.9K | -157.5% |
| FY2017 | $575.8K | -58.3% |
| FY2016 | $1.4M | +190.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026